Ken Takai

3.9k total citations · 2 hit papers
17 papers, 3.0k citations indexed

About

Ken Takai is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Ken Takai has authored 17 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Ken Takai's work include Cancer Cells and Metastasis (4 papers), T-cell and Retrovirus Studies (3 papers) and Metabolism and Genetic Disorders (3 papers). Ken Takai is often cited by papers focused on Cancer Cells and Metastasis (4 papers), T-cell and Retrovirus Studies (3 papers) and Metabolism and Genetic Disorders (3 papers). Ken Takai collaborates with scholars based in Japan, United States and Taiwan. Ken Takai's co-authors include Zena Werb, Valerie M. Weaver, Pengfei Lu, Kai Kessenbrock, Devon A. Lawson, Sanjeev Balakrishnan, Andrei Goga, Alicia Y. Zhou, Chih‐Yang Wang and Karin D. Prummel and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Ken Takai

17 papers receiving 2.9k citations

Hit Papers

Extracellular Matrix Degradation and Remodeling in Develo... 2011 2026 2016 2021 2011 2015 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Takai Japan 9 1.2k 894 671 536 491 17 3.0k
Katherine N. Weilbaecher United States 46 2.5k 2.1× 3.2k 3.6× 817 1.2× 1.3k 2.5× 589 1.2× 124 6.1k
Natarajan Muthusamy United States 40 2.3k 1.9× 1.3k 1.4× 511 0.8× 2.0k 3.7× 205 0.4× 177 5.3k
Olaf Heidenreich United Kingdom 36 3.0k 2.5× 613 0.7× 491 0.7× 609 1.1× 146 0.3× 136 4.1k
Gordon Parry United States 22 1.6k 1.4× 790 0.9× 337 0.5× 581 1.1× 635 1.3× 49 3.5k
Thomas D. Mueller Germany 38 2.9k 2.5× 687 0.8× 229 0.3× 400 0.7× 386 0.8× 102 4.9k
Kayla J. Bayless United States 42 2.9k 2.5× 554 0.6× 957 1.4× 917 1.7× 1.3k 2.6× 100 5.7k
Shingo Fujii Japan 49 2.7k 2.3× 2.2k 2.5× 755 1.1× 2.1k 4.0× 276 0.6× 164 8.1k
Shigetaka Asano Japan 41 2.3k 1.9× 1.5k 1.6× 326 0.5× 1.5k 2.8× 402 0.8× 207 5.8k
Judith Aggeler United States 19 1.1k 0.9× 609 0.7× 450 0.7× 189 0.4× 583 1.2× 25 2.5k
Hidetoshi Mori United States 23 1.4k 1.2× 1.7k 1.8× 1.3k 1.9× 332 0.6× 823 1.7× 52 3.5k

Countries citing papers authored by Ken Takai

Since Specialization
Citations

This map shows the geographic impact of Ken Takai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Takai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Takai more than expected).

Fields of papers citing papers by Ken Takai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Takai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Takai. The network helps show where Ken Takai may publish in the future.

Co-authorship network of co-authors of Ken Takai

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Takai. A scholar is included among the top collaborators of Ken Takai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Takai. Ken Takai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nagai, Shigenori E., Yasuhito Kobayashi, Ken Takai, et al.. (2021). Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer. Scientific Reports. 11(1). 14238–14238. 4 indexed citations
2.
Takai, Ken, Allison P. Drain, Devon A. Lawson, et al.. (2018). Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers. Genes & Development. 32(3-4). 244–257. 56 indexed citations
3.
Okada, Akira, et al.. (2016). Evaluation of Bacillus oleronius as a Biological Indicator for Terminal Sterilization of Large-Volume Parenterals. PDA Journal of Pharmaceutical Science and Technology. 70(1). 30–38. 6 indexed citations
4.
Kurozumi, Sasagu, Kenichi Inoue, Masafumi Kurosumi, et al.. (2016). Values of tumor-infiltrating lymphocytes (TILs), CD8+ TILs, and PDL-1 for predicting pathological complete response and prognosis in HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab.. Journal of Clinical Oncology. 34(15_suppl). 589–589. 1 indexed citations
5.
Takai, Ken, Annie Le, Valerie M. Weaver, & Zena Werb. (2016). Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Oncotarget. 7(50). 82889–82901. 163 indexed citations
6.
Lawson, Devon A., Nirav R. Bhakta, Kai Kessenbrock, et al.. (2015). Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature. 526(7571). 131–135. 690 indexed citations breakdown →
7.
Tanaka, Azusa, Jun‐ichirou Yasunaga, Ken Takai, & Masao Matsuoka. (2014). Molecular mechanisms of apoptosis suppression by HTLV-1 bZIP factor in HTLV-1 infected cells. Retrovirology. 11(S1). 1 indexed citations
8.
Tanaka, Azusa, Jun‐ichirou Yasunaga, Ken Takai, & Masao Matsuoka. (2013). HTLV-1 bZIP Factor Suppresses Apoptosis by Attenuating the Function of FoxO3a and Altering Its Localization. Cancer Research. 74(1). 188–200. 60 indexed citations
9.
Satou, Yorifumi, Jun‐ichirou Yasunaga, Tiejun Zhao, et al.. (2011). HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo. PLoS Pathogens. 7(2). e1001274–e1001274. 238 indexed citations
10.
Lu, Pengfei, Ken Takai, Valerie M. Weaver, & Zena Werb. (2011). Extracellular Matrix Degradation and Remodeling in Development and Disease. Cold Spring Harbor Perspectives in Biology. 3(12). a005058–a005058. 1679 indexed citations breakdown →
11.
Takai, Ken. (2008). Methanogenesis at 122°C renews the upper temperature limit for life and the stable carbon isotopic fractionation of microbial methanogenesis. GeCAS. 72(12). 1 indexed citations
12.
Takai, Ken, Shuichi Sakamoto, Tatsunori Sakai, et al.. (2008). A Potential Link between Alternative Splicing of theNBS1Gene and DNA Damage/Environmental Stress. Radiation Research. 170(1). 33–40. 5 indexed citations
13.
Sako, Yoshihiko, et al.. (2006). Biochemical relationship of phosphoenolpyruvate carboxylases (PEPCs) from thermophilic archaea. FEMS Microbiology Letters. 153(1). 159–165. 6 indexed citations
14.
Takai, Ken, Takuro Nunoura, Yoshihiko Sako, & Aritsune Uchida. (1998). Acquired Thermotolerance and Temperature-Induced Protein Accumulation in the Extremely Thermophilic Bacterium Rhodothermus obamensis. Journal of Bacteriology. 180(10). 2770–2774. 10 indexed citations
15.
Takai, Ken, Yoshihiko Sako, Aya Uchida, & Y. Ishida. (1997). Extremely Thermostable Phosphoenolpyruvate Carboxylase from an Extreme Thermophile, Rhodothermus obamensis. The Journal of Biochemistry. 122(1). 32–40. 11 indexed citations
16.
Takai, Ken, Yoshihiko Sako, & Aritsune Uchida. (1997). Extrinsic thermostabilization factors and thermodenaturation mechanisms for phosphoenolpyruvate carboxylase (PEPC) from an extremely thermophilic bacterium Rhodothermus obamensis. Journal of Fermentation and Bioengineering. 84(4). 291–299. 2 indexed citations
17.
Sako, Yoshihiko, Ken Takai, Aritsune Uchida, & Yūzaburō Ishida. (1996). Purification and characterization of phosphoenolpyruvate carboxylase from the hyperthermophilic archaeon Methanothermus sociabilis. FEBS Letters. 392(2). 148–152. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026